about
Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor TherapyViral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacsEpigenetic modification of FOXP3 in patients with chronic HIV infection.Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2).HIV-Induced Epigenetic Alterations in Host Cells.Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis.Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker ProfilesImprovement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade
P50
Q36881967-287C09D1-9814-4138-8E85-9436F6393C0BQ37120936-6FB55519-E63C-42BA-82AC-C7F6900EDBB7Q37412137-AFFE50F1-0069-4819-B59B-5ACF73FF8F39Q37704680-6B7F1903-600B-4A02-9E38-0C0532EE8130Q38667121-A3493D21-CF3F-4AB2-A962-78BB5E1EECA2Q39241303-42A5A6C2-97D8-4A02-9A68-A4443717BF90Q40451354-A517F3ED-6490-4D31-A20C-79C1766E3D71Q47554082-77F68AA1-36BC-4C69-AC8B-5867AA18A9DAQ64227790-8FD9143E-9189-4533-87A3-E4F6DCF90FF2Q91618349-EE63D521-EC25-4741-A739-9CDC83D771DB
P50
description
investigador
@es
researcher
@en
name
Enass A Abdel-Hameed
@en
type
label
Enass A Abdel-Hameed
@en
prefLabel
Enass A Abdel-Hameed
@en
P31
P496
0000-0002-6921-9081